OK, I have been lurking on this board for over 5 years now, I guess it is finally time for my first post. Everyone here seems to be arguing about what a fair stock price would be post AD approval, think about this for awhile. If Anavex wanted to do the world a favor, they would price A2-73 right at half the cost of the mab drug overall cost per patient. And that cost would be $50.00 per pill. I would have to think that there might be a little bit of profit margin there? Now plug that number into your spreadsheets and tell me what the share price would be.
Bullish
Market Data 
Markets 
